Appendicular Lean Mass and the Risk of Stroke and Alzheimer's Disease: a Mendelian Randomization Study

Overview

Journal BMC Geriatr

Publisher Biomed Central

Specialty Geriatrics

Date 2024 May 18

PMID 38762444

Authors

Yueli Zhu

Feng Zhu

Xiaoming Guo

Shunmei Huang

Yunmei Yang

Qin Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Appendicular lean mass (ALM) is a good predictive biomarker for sarcopenia. And previous studies have reported the association between ALM and stroke or Alzheimer's disease (AD), however, the causal relationship is still unclear, The purpose of this study was to evaluate whether genetically predicted ALM is causally associated with the risk of stroke and AD by performing Mendelian randomization (MR) analyses.

Methods: A two-sample MR study was designed. Genetic variants associated with the ALM were obtained from a large genome-wide association study (GWAS) and utilized as instrumental variables (IVs). Summary-level data for stroke and AD were generated from the corresponding GWASs. We used random-effect inverse-variance weighted (IVW) as the main method for estimating causal effects, complemented by several sensitivity analyses, including the weighted median, MR-Egger, and MR-pleiotropy residual sum and outlier (MR-PRESSO) methods. Multivariable analysis was further conducted to adjust for confounding factors, including body mass index (BMI), type 2 diabetes mellitus (T2DM), low density lipoprotein-C (LDL-C), and atrial fibrillation (AF).

Results: The present MR study indicated significant inverse associations of genetically predicted ALM with any ischemic stroke ([AIS], odds ratio [OR], 0.93; 95% confidence interval [CI], 0.89-0.97; P = 0.002) and AD (OR, 090; 95% CI 0.85-0.96; P = 0.001). Regarding the subtypes of AIS, genetically predicted ALM was related to the risk of large artery stroke ([LAS], OR, 0.86; 95% CI 0.77-0.95; P = 0.005) and small vessel stroke ([SVS], OR, 0.80; 95% CI 0.73-0.89; P < 0.001). Regarding multivariable MR analysis, ALM retained the stable effect on AIS when adjusting for BMI, LDL-C, and AF, while a suggestive association was observed after adjusting for T2DM. And the estimated effect of ALM on LAS was significant after adjustment for BMI and AF, while a suggestive association was found after adjusting for T2DM and LDL-C. Besides, the estimated effects of ALM were still significant on SVS and AD after adjustment for BMI, T2DM, LDL-C, and AF.

Conclusions: The two-sample MR analysis indicated that genetically predicted ALM was negatively related to AIS and AD. And the subgroup analysis of AIS revealed a negative causal effect of genetically predicted ALM on LAS or SVS. Future studies are required to further investigate the underlying mechanisms.

References

Hoffmann T, Choquet H, Yin J, Banda Y, Kvale M, Glymour M . A Large Multiethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Novel Loci. Genetics. 2018; 210(2):499-515. PMC: 6216593. DOI: 10.1534/genetics.118.301479. View

Burgess S, Thompson S . Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017; 32(5):377-389. PMC: 5506233. DOI: 10.1007/s10654-017-0255-x. View

Nozoe M, Kanai M, Kubo H, Yamamoto M, Shimada S, Mase K . Prestroke Sarcopenia and Stroke Severity in Elderly Patients with Acute Stroke. J Stroke Cerebrovasc Dis. 2019; 28(8):2228-2231. DOI: 10.1016/j.jstrokecerebrovasdis.2019.05.001. View

Yu J, Kim R, Jung J, Park S, Lee D, Cho H . Sarcopenia is associated with decreased gray matter volume in the parietal lobe: a longitudinal cohort study. BMC Geriatr. 2021; 21(1):622. PMC: 8565062. DOI: 10.1186/s12877-021-02581-4. View

Cabett Cipolli G, Sanches Yassuda M, Aprahamian I . Sarcopenia Is Associated with Cognitive Impairment in Older Adults: A Systematic Review and Meta-Analysis. J Nutr Health Aging. 2019; 23(6):525-531. DOI: 10.1007/s12603-019-1188-8. View

Studenski S, Peters K, Alley D, Cawthon P, McLean R, Harris T . The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014; 69(5):547-58. PMC: 3991146. DOI: 10.1093/gerona/glu010. View

Beijers H, Ferreira I, Bravenboer B, Henry R, Schalkwijk C, Dekker J . Higher central fat mass and lower peripheral lean mass are independent determinants of endothelial dysfunction in the elderly: the Hoorn study. Atherosclerosis. 2014; 233(1):310-8. DOI: 10.1016/j.atherosclerosis.2013.12.002. View

Peng T, Chen W, Wu L, Chang Y, Kao T . Sarcopenia and cognitive impairment: A systematic review and meta-analysis. Clin Nutr. 2020; 39(9):2695-2701. DOI: 10.1016/j.clnu.2019.12.014. View

Hsu F, Lenchik L, Nicklas B, Lohman K, Register T, Mychaleckyj J . Heritability of body composition measured by DXA in the diabetes heart study. Obes Res. 2005; 13(2):312-9. DOI: 10.1038/oby.2005.42. View

10.

Franzoni F, Scarfo G, Guidotti S, Fusi J, Asomov M, Pruneti C . Oxidative Stress and Cognitive Decline: The Neuroprotective Role of Natural Antioxidants. Front Neurosci. 2021; 15:729757. PMC: 8548611. DOI: 10.3389/fnins.2021.729757. View

11.

Endres M, Moro M, Nolte C, Dames C, Buckwalter M, Meisel A . Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke. Circ Res. 2022; 130(8):1167-1186. DOI: 10.1161/CIRCRESAHA.121.319994. View

12.

Xue A, Wu Y, Zhu Z, Zhang F, Kemper K, Zheng Z . Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018; 9(1):2941. PMC: 6063971. DOI: 10.1038/s41467-018-04951-w. View

13.

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

14.

Pei Y, Liu Y, Yang X, Zhang H, Feng G, Wei X . The genetic architecture of appendicular lean mass characterized by association analysis in the UK Biobank study. Commun Biol. 2020; 3(1):608. PMC: 7585446. DOI: 10.1038/s42003-020-01334-0. View

15.

Dalle S, Rossmeislova L, Koppo K . The Role of Inflammation in Age-Related Sarcopenia. Front Physiol. 2018; 8:1045. PMC: 5733049. DOI: 10.3389/fphys.2017.01045. View

16.

Koito Y, Yanishi M, Kimura Y, Tsukaguchi H, Kinoshita H, Matsuda T . Serum Brain-Derived Neurotrophic Factor and Myostatin Levels Are Associated With Skeletal Muscle Mass in Kidney Transplant Recipients. Transplant Proc. 2021; 53(6):1939-1944. DOI: 10.1016/j.transproceed.2021.04.021. View

17.

Hemani G, Zheng J, Elsworth B, Wade K, Haberland V, Baird D . The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018; 7. PMC: 5976434. DOI: 10.7554/eLife.34408. View

18.

Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker S . Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project). BMJ. 2022; 377:e068788. PMC: 9092831. DOI: 10.1136/bmj-2021-068788. View

19.

Burgess S, Scott R, Timpson N, Davey Smith G, Thompson S . Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 2015; 30(7):543-52. PMC: 4516908. DOI: 10.1007/s10654-015-0011-z. View

20.

Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T . Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018; 48(1):16-31. PMC: 6322506. DOI: 10.1093/ageing/afy169. View